A Randomized, Multi-Center Study of the Pimecrolimus-Eluting (Corio) and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System (SymBio) in Patients With De Novo Lesions of the Native Coronary Arteries.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2013
At a glance
- Drugs Paclitaxel; Pimecrolimus
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Registrational; Therapeutic Use
- Acronyms GENESIS
- 14 May 2012 Planned end date changed from 1 Apr 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 27 Apr 2010 Cordis-Corporation added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
- 27 Apr 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History